Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Bao fu kang shuan for cervical HR-HPV16/18 infection with LSIL
CTR20210287Phase 2Active
- Sponsor
- Hainan Bikai Pharmaceutical Co., Ltd.
- Start
- Apr 2021
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of baofukang shuan in human papillomavirus infection, cervical intraepithelial neoplasia (CIN), sponsored by Hainan Bikai Pharmaceutical Co., Ltd.. Started Apr 2021; status: active.
02
Drugs
baofukang shuan
03
Conditions
human papillomavirus infectioncervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on CTR20210287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210287.